Navigation Links
NHS reforms not benefiting patients

Although the new government health refoms have cost millions of pounds to the NHS, they seem to have proved to be of very little benefit for the patients//.

Cosultants pay and pension have been increased in the NHS but the King’s fund report state that there is no difference to patient care.

This has put a lot of pressure on the budgets of the hospitals. There has been no planning and no guidance on this. Many have seen these contracts as 'a box to be ticked' making it a very costly exercise.

Consultants have been asked to work for an extra four hours every week for the NHS, on the assumption that they would give more attention to the NHS before their private practice.

Of course this has only led to a lot of clock watching and reluctance to work beyond stipulated hours

According to the King’s fund, there are 30,000 consultants whose salaries have increased by almost 36% from 2001. As per the new agreement the consultants will have to work for a total of 40 hours a week. They earn extra money while working more sessions.

'So far, it is less clear what the service and patients have got out of the deal beyond greater transparency of consultant workloads,' the report said.


'"/>




Page: 1

Related medicine news :

1. An urgent need for prison reforms: California!
2. Stagnant IMR calls for improved health sector reforms
3. HIV infected patients can travel safely abroad
4. New vaccine helps allergy and asthma patients
5. Doctors operate upon patients in candlelight- latest from the quake scene
6. New vaccine helps allergy and asthma patients
7. Are cancer patients being taken for a ride?
8. Alternative medicine more popular among HIV positive patients
9. ATG useful in transplant patients as substitute for steroids
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Distraction therapy found very effective in postoperative patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... 2017 Non-alcoholic steatohepataitis (NASH) Pipeline ... drugs being developed for the treatment of ... that are in various phases of development ... on novel pharmacologic drugs & regenerative medicines ... recombinant proteins and RNA-based therapeutics, but excludes ...
(Date:2/24/2017)... Wyoming , Feb. 24, 2017  Xynomic Pharmaceuticals, ... today announced that it has acquired exclusive worldwide ... potentially best-in-class innovative HDAC inhibitor targeting hematological and ... of 14 Phase 1 and 2 clinical trials ... Asia have already been completed, demonstrating ...
Breaking Medicine Technology: